121 related articles for article (PubMed ID: 38031811)
1. Real-World Evidence of Intra-institutional Performance Variation in Indefinite Diagnosis of Pleural Effusion Cytology.
Chen KH; Kuo CY; Chen TD
Arch Pathol Lab Med; 2023 Nov; ():. PubMed ID: 38031811
[TBL] [Abstract][Full Text] [Related]
2. Optimal Volume Assessment for Serous Fluid Cytology.
Christofidis K; Theochari M; Mavropoulos Papoudas S; Kiohou L; Sousouris S; Dimitriadou A; Volakakis N; Maounis N; Mikou P
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672252
[TBL] [Abstract][Full Text] [Related]
3. The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology.
Kala C; Kala S; Singh A; Jauhari RK; Bajpai A; Khan L
J Cytol; 2023; 40(4):159-164. PubMed ID: 38058672
[TBL] [Abstract][Full Text] [Related]
4. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.
Sachan R; Gupta A; Awasthi PN; Singh P; Anand N; Chandra S; Gaur G; Husain N; Sachan KD
J Am Soc Cytopathol; 2023; 12(5):351-361. PubMed ID: 37244848
[TBL] [Abstract][Full Text] [Related]
5. Cytohistological Correlation in Pleural Effusions Based on the International System for Reporting Serous Fluid Cytopathology.
Pinto D; Cruz E; Branco D; Linares C; Carvalho C; Silva A; Chorão M; Schmitt F
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34203073
[TBL] [Abstract][Full Text] [Related]
6. Application of the newly published International System for Reporting Serous Fluid Cytopathology in atypical and suspicious diagnosis: a four-year retrospective analysis.
Shen Y; Gosnell JM; Nawgiri R; Muthukumarana V
J Am Soc Cytopathol; 2024 Mar; ():. PubMed ID: 38637263
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.
Lu CH; Liu CY; Jhuang JY; Chen CC
Cancer Cytopathol; 2024 Mar; 132(3):169-178. PubMed ID: 38062987
[TBL] [Abstract][Full Text] [Related]
8. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
9. Risk Stratification of Pleural Fluid Cytology Based on the International System for Reporting Serous Fluid Cytology in a Tertiary Care Centre.
Bharti S; Nalwa A; Elhence PA; Rao M; Bharti JN; Khera S; Vedant D; Vishwajeet V; Goel A
Acta Cytol; 2022; 66(5):449-456. PubMed ID: 35413720
[TBL] [Abstract][Full Text] [Related]
10. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
Ahuja S; Malviya A
Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
[TBL] [Abstract][Full Text] [Related]
11. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.
Wang M; Sun T; Jiao J; Wang H
Cancer Cytopathol; 2023 Jul; 131(7):433-441. PubMed ID: 36973963
[TBL] [Abstract][Full Text] [Related]
12. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
[TBL] [Abstract][Full Text] [Related]
13. Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".
Kapoor S; Samanta S; Kaur K
J Cytol; 2024; 41(2):96-104. PubMed ID: 38779601
[TBL] [Abstract][Full Text] [Related]
14. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.
Jha S; Sethy M; Adhya AK
Diagn Cytopathol; 2021 Oct; 49(10):1089-1098. PubMed ID: 34289263
[TBL] [Abstract][Full Text] [Related]
15. The Role of Novel Tiered Reporting System in Serous Fluid Cytology and Risk of Malignancy Assessment: A Retrospective Study in a Tertiary Care Center.
Alashetty S; Sadasivan B; Dharmalingam P; Rajagopal N; Kavya L; Pai MM
J Cytol; 2023; 40(3):107-113. PubMed ID: 37745807
[TBL] [Abstract][Full Text] [Related]
16. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
[TBL] [Abstract][Full Text] [Related]
17. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
Straccia P; Chiappetta M; Magnini D; Cancellieri A
Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
[TBL] [Abstract][Full Text] [Related]
18. Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.
Pergaris A; Stefanou D; Keramari P; Sousouris S; Kavantzas N; Gogas H; Mikou P
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943460
[TBL] [Abstract][Full Text] [Related]
19. Application of algorithmic cytomorphological assessment and immunocytochemistry with the international system for reporting serous fluid cytopathology on pericardial fluid cytology.
Li JJX; Cheung W; Ng JKM; Tse GM
J Clin Pathol; 2023 Aug; ():. PubMed ID: 37643837
[TBL] [Abstract][Full Text] [Related]
20. Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
Rodriguez EF; Pastorello RG; Morris P; Saieg M; Chowsilpa S; Maleki Z
Am J Clin Pathol; 2020 Aug; 154(3):394-402. PubMed ID: 32525969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
